Acute skin reactions associated with radiotherapy can be distressing and can lead to treatment interruption. Anticipating, assessing and managing the problem according to best evidence can make a big difference. Radiotherapy-related toxicity occurs because of [more]
Once used primarily to detect large polyps and tumours, endoscopy has now become an essential tool for early diagnosis, curative treatment and palliation for gastrointestinal cancer. This is an edited version of a presentation delivered [more]
This egrandround was first presented by Caroline Moore, from University College Hospital London, as a live webcast for the European School of Oncology. It is edited by Susan Mayor. The webcast of this and other [more]
TKIs are involved in treating an increasing number of cancer indications. Doctors need to be aware of the range of potentially serious side effects associated with these drugs, and know how to mitigate them, to [more]
Showing that a new drug can keep advanced cancers from progressing, or stop early cancers from returning, is quicker, cheaper and easier than showing that it helps patients live longer. But how can we judge [more]
When chemotherapy drugs leak from the veins it can cause serious injury to the patient, greatly heighten their fears of undergoing future treatment cycles, and undermine their trust in their medical team. Knowing how to [more]
Getting cancer as a teenager or young adult can severely disrupt an important period of emotional, physical and social transition. Tailoring services to fit the particular needs of this age group can make a huge [more]
Pharmacokinetics within tumour cells play an important role in the development of resistance. A better understanding of the mechanisms involved is important for devising treatment strategies to extend tumour response. We know that cancer cells [more]
Screening breast cancer patients for lymphoedema makes it possible to identify problems early and take action to halt its progression. Oncologists have an important role to play, particularly given the rise in lymphoedema rates that [more]
The European Commission is developing a Europe-wide accreditation scheme for breast centres to push up standards of diagnosis and care. Here experts from both sides of the Atlantic take a look at existing schemes, the [more]
Patients who are receiving adequate nutrition have a better prognosis, respond better to chemotherapy and can tolerate higher doses of anticancer treatments. It is therefore important for oncologists to assess and manage malnutrition. Malnutrition, which [more]
Modern tools of biological investigation give us opportunities to develop drugs much more efficiently. The president of Europes most important trials organisation explains how these opportunities can and must be exploited to start [more]
Thrombosis is the second most common preventable cause of death in patients with cancer, so oncologists need to know how to identify who is at risk, and strategies for prevention and treatment. This overview presents [more]